Sign in
4

Changes in Ownership

MapLight Therapeutics, Inc. Filed Acc 0001728746-26-000014

Chief Scientific Officer sold 22,082 shares at $12.54 ($276,908)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lillie James Woodruff · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-03 Sale : show line 1 in the form 10b5-1 −22,082 $12.54 $276,908 202,380 D
Open-market sales · 22,082 sh · avg $12.54 · $276,908
Loading xslF345X06/form4-08052026_120851.xml…